Análise de percentual econômico dos medicamentos adquiridos por via de ações judiciais Article Swipe
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.21115/jbes.v8.n2.p125-131
Objetivo: Propôs-se avaliar o percentual econômico do processo de compra dos medicamentos por ação judicial do DRSII (Departamento Regional de Saúde) do estado de São Paulo. Métodos: Trata-se de um estudo descritivo. Foram coletados os seguintes dados nas ações judiciais: nome do medicamento, quantidade fornecida, preço de compra e preço de tabela. Calculou-se o preço unitário e o preço total, segundo o valor pago e o preço de tabela de cada medicamento. Para a análise econômica, utilizou-se o indicador de resultado descrito no “Manual de indicadores principias de situação de políticas farmacêuticas”, preconizado pela OMS. Resultados: Dados evidenciaram que o processo de aquisição foi efetivo porque gerou uma economia de 51,6% (2,2-99,1%). No entanto, em alguns itens como a enoxaparina e cloridrato de pioglitazona, o processo de aquisição poderia melhorar porque houve um prejuízo de 404,4% e 139,0%, respectivamente. Conclusão: A maioria dos itens adquiridos foi da atenção básica de saúde (89,4 %), evidenciando conhecimento das petições dos medicamentos do Componente Especializado da Assistência Farmacêutica e seus Protocolos Clínicos. Considera-se que a análise do percentual econômico é um indicador de resultado importante porque contribui para avaliar a eficiência do processo de aquisição, identifica os municípios que mais ações peticionam, auxiliando na avaliação e atualização da REMUME (Relação Municipal de Medicamentos Essenciais) e o desempenho da assistência farmacêutica municipal.
Related Topics
- Type
- article
- Language
- pt
- Landing Page
- http://doi.org/10.21115/jbes.v8.n2.p125-131
- https://doi.org/10.21115/jbes.v8.n2.p125-131
- OA Status
- diamond
- Cited By
- 7
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2521174574
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2521174574Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21115/jbes.v8.n2.p125-131Digital Object Identifier
- Title
-
Análise de percentual econômico dos medicamentos adquiridos por via de ações judiciaisWork title
- Type
-
articleOpenAlex work type
- Language
-
ptPrimary language
- Publication year
-
2016Year of publication
- Publication date
-
2016-08-20Full publication date if available
- Authors
-
Vitória Picolini, José Fernando Rinaldi de Alvarenga, Juliana Fila, Patrícia de Carvalho MastroianniList of authors in order
- Landing page
-
https://doi.org/10.21115/jbes.v8.n2.p125-131Publisher landing page
- PDF URL
-
https://doi.org/10.21115/jbes.v8.n2.p125-131Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.21115/jbes.v8.n2.p125-131Direct OA link when available
- Concepts
-
Physics, Humanities, PhilosophyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 1, 2023: 3, 2022: 1, 2021: 2Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2521174574 |
|---|---|
| doi | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| ids.doi | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| ids.mag | 2521174574 |
| ids.openalex | https://openalex.org/W2521174574 |
| fwci | 0.0 |
| type | article |
| title | Análise de percentual econômico dos medicamentos adquiridos por via de ações judiciais |
| biblio.issue | 2 |
| biblio.volume | 8 |
| biblio.last_page | 131 |
| biblio.first_page | 125 |
| topics[0].id | https://openalex.org/T13915 |
| topics[0].field.id | https://openalex.org/fields/33 |
| topics[0].field.display_name | Social Sciences |
| topics[0].score | 0.9987000226974487 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3312 |
| topics[0].subfield.display_name | Sociology and Political Science |
| topics[0].display_name | Public Health in Brazil |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C121332964 |
| concepts[0].level | 0 |
| concepts[0].score | 0.44051557779312134 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[0].display_name | Physics |
| concepts[1].id | https://openalex.org/C15708023 |
| concepts[1].level | 1 |
| concepts[1].score | 0.40914955735206604 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[1].display_name | Humanities |
| concepts[2].id | https://openalex.org/C138885662 |
| concepts[2].level | 0 |
| concepts[2].score | 0.24960318207740784 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[2].display_name | Philosophy |
| keywords[0].id | https://openalex.org/keywords/physics |
| keywords[0].score | 0.44051557779312134 |
| keywords[0].display_name | Physics |
| keywords[1].id | https://openalex.org/keywords/humanities |
| keywords[1].score | 0.40914955735206604 |
| keywords[1].display_name | Humanities |
| keywords[2].id | https://openalex.org/keywords/philosophy |
| keywords[2].score | 0.24960318207740784 |
| keywords[2].display_name | Philosophy |
| language | pt |
| locations[0].id | doi:10.21115/jbes.v8.n2.p125-131 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210220290 |
| locations[0].source.issn | 2175-2095, 2359-1641 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2175-2095 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Jornal Brasileiro de Economia da Saúde |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Jornal Brasileiro de Economia da Saúde |
| locations[0].landing_page_url | http://doi.org/10.21115/jbes.v8.n2.p125-131 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5079966158 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Vitória Picolini |
| authorships[0].countries | BR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I879563668 |
| authorships[0].affiliations[0].raw_affiliation_string | . Graduanda em Farmácia-Bioquímica. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Univer-sidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. |
| authorships[0].institutions[0].id | https://openalex.org/I879563668 |
| authorships[0].institutions[0].ror | https://ror.org/00987cb86 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I879563668 |
| authorships[0].institutions[0].country_code | BR |
| authorships[0].institutions[0].display_name | Universidade Estadual Paulista (Unesp) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Vitória Picolini |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | . Graduanda em Farmácia-Bioquímica. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Univer-sidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. |
| authorships[1].author.id | https://openalex.org/A5079030520 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1137-1873 |
| authorships[1].author.display_name | José Fernando Rinaldi de Alvarenga |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I71999127 |
| authorships[1].affiliations[0].raw_affiliation_string | . Doutorando. Departament de Nutrició, Ciències de l'Alimentació i Gastronomia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Espanha. |
| authorships[1].institutions[0].id | https://openalex.org/I71999127 |
| authorships[1].institutions[0].ror | https://ror.org/021018s57 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I71999127 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Universitat de Barcelona |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | José Fernando Alvarenga |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | . Doutorando. Departament de Nutrició, Ciències de l'Alimentació i Gastronomia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Espanha. |
| authorships[2].author.id | https://openalex.org/A5050218843 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Juliana Fila |
| authorships[2].countries | BR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I879563668 |
| authorships[2].affiliations[0].raw_affiliation_string | . Graduanda em Farmácia-Bioquímica. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Univer-sidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. |
| authorships[2].institutions[0].id | https://openalex.org/I879563668 |
| authorships[2].institutions[0].ror | https://ror.org/00987cb86 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I879563668 |
| authorships[2].institutions[0].country_code | BR |
| authorships[2].institutions[0].display_name | Universidade Estadual Paulista (Unesp) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Juliana Fila |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | . Graduanda em Farmácia-Bioquímica. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Univer-sidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. |
| authorships[3].author.id | https://openalex.org/A5046629578 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8467-7278 |
| authorships[3].author.display_name | Patrícia de Carvalho Mastroianni |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I879563668 |
| authorships[3].affiliations[0].raw_affiliation_string | . Professora. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. Nome |
| authorships[3].institutions[0].id | https://openalex.org/I879563668 |
| authorships[3].institutions[0].ror | https://ror.org/00987cb86 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I879563668 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Universidade Estadual Paulista (Unesp) |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Patrícia Mastroianni |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | . Professora. Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista "Júlio de Mesquita Filho" -UNESP, Araraquara, SP. Nome |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Análise de percentual econômico dos medicamentos adquiridos por via de ações judiciais |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13915 |
| primary_topic.field.id | https://openalex.org/fields/33 |
| primary_topic.field.display_name | Social Sciences |
| primary_topic.score | 0.9987000226974487 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3312 |
| primary_topic.subfield.display_name | Sociology and Political Science |
| primary_topic.display_name | Public Health in Brazil |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2935759653, https://openalex.org/W3105167352, https://openalex.org/W54078636, https://openalex.org/W2954470139, https://openalex.org/W1501425562, https://openalex.org/W2902782467, https://openalex.org/W3084825885, https://openalex.org/W2298861036, https://openalex.org/W2271181815 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 3 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 2 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21115/jbes.v8.n2.p125-131 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210220290 |
| best_oa_location.source.issn | 2175-2095, 2359-1641 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2175-2095 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Jornal Brasileiro de Economia da Saúde |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Jornal Brasileiro de Economia da Saúde |
| best_oa_location.landing_page_url | http://doi.org/10.21115/jbes.v8.n2.p125-131 |
| primary_location.id | doi:10.21115/jbes.v8.n2.p125-131 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210220290 |
| primary_location.source.issn | 2175-2095, 2359-1641 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2175-2095 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Jornal Brasileiro de Economia da Saúde |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | https://doi.org/10.21115/jbes.v8.n2.p125-131 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Jornal Brasileiro de Economia da Saúde |
| primary_location.landing_page_url | http://doi.org/10.21115/jbes.v8.n2.p125-131 |
| publication_date | 2016-08-20 |
| publication_year | 2016 |
| referenced_works_count | 0 |
| abstract_inverted_index.A | 140 |
| abstract_inverted_index.a | 73, 118, 171, 186 |
| abstract_inverted_index.e | 48, 56, 64, 120, 136, 165, 202, 211 |
| abstract_inverted_index.o | 3, 53, 57, 61, 65, 77, 99, 124, 212 |
| abstract_inverted_index.No | 112 |
| abstract_inverted_index.da | 146, 162, 204, 214 |
| abstract_inverted_index.de | 8, 19, 23, 28, 46, 50, 67, 69, 79, 84, 87, 89, 101, 109, 122, 126, 134, 149, 179, 190, 208 |
| abstract_inverted_index.do | 6, 15, 21, 41, 159, 173, 188 |
| abstract_inverted_index.em | 114 |
| abstract_inverted_index.na | 200 |
| abstract_inverted_index.no | 82 |
| abstract_inverted_index.os | 34, 193 |
| abstract_inverted_index.um | 29, 132, 177 |
| abstract_inverted_index.é | 176 |
| abstract_inverted_index.%), | 152 |
| abstract_inverted_index.das | 155 |
| abstract_inverted_index.dos | 10, 142, 157 |
| abstract_inverted_index.foi | 103, 145 |
| abstract_inverted_index.nas | 37 |
| abstract_inverted_index.por | 12 |
| abstract_inverted_index.que | 98, 170, 195 |
| abstract_inverted_index.uma | 107 |
| abstract_inverted_index.OMS. | 94 |
| abstract_inverted_index.Para | 72 |
| abstract_inverted_index.São | 24 |
| abstract_inverted_index.cada | 70 |
| abstract_inverted_index.como | 117 |
| abstract_inverted_index.mais | 196 |
| abstract_inverted_index.nome | 40 |
| abstract_inverted_index.pago | 63 |
| abstract_inverted_index.para | 184 |
| abstract_inverted_index.pela | 93 |
| abstract_inverted_index.seus | 166 |
| abstract_inverted_index.(89,4 | 151 |
| abstract_inverted_index.51,6% | 110 |
| abstract_inverted_index.DRSII | 16 |
| abstract_inverted_index.Dados | 96 |
| abstract_inverted_index.Foram | 32 |
| abstract_inverted_index.dados | 36 |
| abstract_inverted_index.gerou | 106 |
| abstract_inverted_index.houve | 131 |
| abstract_inverted_index.itens | 116, 143 |
| abstract_inverted_index.valor | 62 |
| abstract_inverted_index.404,4% | 135 |
| abstract_inverted_index.Paulo. | 25 |
| abstract_inverted_index.REMUME | 205 |
| abstract_inverted_index.alguns | 115 |
| abstract_inverted_index.ação | 13 |
| abstract_inverted_index.compra | 9, 47 |
| abstract_inverted_index.estado | 22 |
| abstract_inverted_index.estudo | 30 |
| abstract_inverted_index.porque | 105, 130, 182 |
| abstract_inverted_index.preço | 45, 49, 54, 58, 66 |
| abstract_inverted_index.saúde | 150 |
| abstract_inverted_index.tabela | 68 |
| abstract_inverted_index.total, | 59 |
| abstract_inverted_index.139,0%, | 137 |
| abstract_inverted_index.Saúde) | 20 |
| abstract_inverted_index.avaliar | 2, 185 |
| abstract_inverted_index.ações | 38, 197 |
| abstract_inverted_index.básica | 148 |
| abstract_inverted_index.efetivo | 104 |
| abstract_inverted_index.maioria | 141 |
| abstract_inverted_index.poderia | 128 |
| abstract_inverted_index.segundo | 60 |
| abstract_inverted_index.tabela. | 51 |
| abstract_inverted_index.Regional | 18 |
| abstract_inverted_index.Trata-se | 27 |
| abstract_inverted_index.análise | 74, 172 |
| abstract_inverted_index.descrito | 81 |
| abstract_inverted_index.economia | 108 |
| abstract_inverted_index.entanto, | 113 |
| abstract_inverted_index.judicial | 14 |
| abstract_inverted_index.melhorar | 129 |
| abstract_inverted_index.processo | 7, 100, 125, 189 |
| abstract_inverted_index.Municipal | 207 |
| abstract_inverted_index.Métodos: | 26 |
| abstract_inverted_index.Objetivo: | 0 |
| abstract_inverted_index.atenção | 147 |
| abstract_inverted_index.coletados | 33 |
| abstract_inverted_index.contribui | 183 |
| abstract_inverted_index.indicador | 78, 178 |
| abstract_inverted_index.prejuízo | 133 |
| abstract_inverted_index.resultado | 80, 180 |
| abstract_inverted_index.seguintes | 35 |
| abstract_inverted_index.unitário | 55 |
| abstract_inverted_index.“Manual | 83 |
| abstract_inverted_index.(Relação | 206 |
| abstract_inverted_index.Clínicos. | 168 |
| abstract_inverted_index.Componente | 160 |
| abstract_inverted_index.Propôs-se | 1 |
| abstract_inverted_index.Protocolos | 167 |
| abstract_inverted_index.adquiridos | 144 |
| abstract_inverted_index.auxiliando | 199 |
| abstract_inverted_index.cloridrato | 121 |
| abstract_inverted_index.desempenho | 213 |
| abstract_inverted_index.econômico | 5, 175 |
| abstract_inverted_index.fornecida, | 44 |
| abstract_inverted_index.identifica | 192 |
| abstract_inverted_index.importante | 181 |
| abstract_inverted_index.judiciais: | 39 |
| abstract_inverted_index.municipal. | 217 |
| abstract_inverted_index.percentual | 4, 174 |
| abstract_inverted_index.petições | 156 |
| abstract_inverted_index.políticas | 90 |
| abstract_inverted_index.principias | 86 |
| abstract_inverted_index.quantidade | 43 |
| abstract_inverted_index.situação | 88 |
| abstract_inverted_index.Calculou-se | 52 |
| abstract_inverted_index.Conclusão: | 139 |
| abstract_inverted_index.Essenciais) | 210 |
| abstract_inverted_index.Resultados: | 95 |
| abstract_inverted_index.aquisição | 102, 127 |
| abstract_inverted_index.avaliação | 201 |
| abstract_inverted_index.descritivo. | 31 |
| abstract_inverted_index.econômica, | 75 |
| abstract_inverted_index.eficiência | 187 |
| abstract_inverted_index.enoxaparina | 119 |
| abstract_inverted_index.indicadores | 85 |
| abstract_inverted_index.municípios | 194 |
| abstract_inverted_index.peticionam, | 198 |
| abstract_inverted_index.preconizado | 92 |
| abstract_inverted_index.utilizou-se | 76 |
| abstract_inverted_index.(2,2-99,1%). | 111 |
| abstract_inverted_index.Assistência | 163 |
| abstract_inverted_index.Considera-se | 169 |
| abstract_inverted_index.Medicamentos | 209 |
| abstract_inverted_index.aquisição, | 191 |
| abstract_inverted_index.assistência | 215 |
| abstract_inverted_index.conhecimento | 154 |
| abstract_inverted_index.evidenciando | 153 |
| abstract_inverted_index.evidenciaram | 97 |
| abstract_inverted_index.medicamento, | 42 |
| abstract_inverted_index.medicamento. | 71 |
| abstract_inverted_index.medicamentos | 11, 158 |
| abstract_inverted_index.(Departamento | 17 |
| abstract_inverted_index.Especializado | 161 |
| abstract_inverted_index.Farmacêutica | 164 |
| abstract_inverted_index.atualização | 203 |
| abstract_inverted_index.farmacêutica | 216 |
| abstract_inverted_index.pioglitazona, | 123 |
| abstract_inverted_index.respectivamente. | 138 |
| abstract_inverted_index.farmacêuticas”, | 91 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.12362319 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |